Literature DB >> 18704304

Repair of rabbit femoral defects with a novel BMP2-derived oligopeptide P24.

Zhixia Duan1, Qixin Zheng, Xiaodong Guo, Changwen Li, Bin Wu, Weigang Wu.   

Abstract

In this study, the bioactivity of a novel BMP2-derived oligopeptide P24 was investigated by using the model of rabbit femoral defect after loaded in the biodegradable poly (lactic acid / glycolic acid / asparagic acid-co-polyethylene glycol) (PLGA-[ASP-PEG]). A 1.5-cm unilateral segmental bone defect was created in the left femoral diaphysis in each of the 30 new zealand white rabbits. The defects of 18 legs filled with BMP2-derived peptide P24 combined with PLGA-[ASP-PEG] scaffold serves as the experimental group, and the defects in the rest 12 rabbits filled with (PLGA-[ASP-PEG]) without P24 as control group. The bone-repairing capability in the target region of the two group was grossly, radiologically, histopathologically and biomechanically evaluated 4, 8 and 12 weeks after the operation. Our results showed that in each group, primary healing of incision was achieved in the two groups. Radiographically, in experimental group, defects were filled with induced callus within 8 weeks, and a cortical bone-like structure was observed in some animals at the 12th week. According to the standardized stage of bone defect repair, 9 (64.28%) achieved grade-4 healing. In contrast, little bone formation was seen in the defects even 12 weeks after the operation, and 5 (62.50%) had grade 0 healing in this group. Histologically, tissue engineering material was mostly absorbed and cartilage was found around implants in the experimental group at the 4th week; 8 weeks after operation, the engineering material was completely absorbed, and formation of woven bone was observed and typical trabecular bone structure could be seen. In control group, 8 weeks after operation, the defect was filled with fibrous tissues, and no bone-like structure was observed. Statistical analysis showed very significant difference in biomechanical indicators between the two groups (P<0.05). It is concluded that new oligopeptide P24 can induce excellent bone regeneration and promote bone repair.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18704304     DOI: 10.1007/s11596-008-0411-3

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  19 in total

Review 1.  Tissue engineering in the twenty-first century.

Authors:  S Terada; M Sato; A Sevy; J P Vacanti
Journal:  Yonsei Med J       Date:  2000-12       Impact factor: 2.759

Review 2.  Bone morphogenetic proteins in human bone regeneration.

Authors:  E H Groeneveld; E H Burger
Journal:  Eur J Endocrinol       Date:  2000-01       Impact factor: 6.664

Review 3.  The ABCs of BMPs.

Authors:  Scott D Boden
Journal:  Orthop Nurs       Date:  2005 Jan-Feb       Impact factor: 0.913

4.  Crystal structure of the BMP-2-BRIA ectodomain complex.

Authors:  T Kirsch; W Sebald; M K Dreyer
Journal:  Nat Struct Biol       Date:  2000-06

5.  BMP-2 antagonists emerge from alterations in the low-affinity binding epitope for receptor BMPR-II.

Authors:  T Kirsch; J Nickel; W Sebald
Journal:  EMBO J       Date:  2000-07-03       Impact factor: 11.598

6.  Activation of osteo-progenitor cells by a novel synthetic peptide derived from the bone morphogenetic protein-2 knuckle epitope.

Authors:  Atsuhiro Saito; Yoshihisa Suzuki; Shin ichi Ogata; Chikara Ohtsuki; Masao Tanihara
Journal:  Biochim Biophys Acta       Date:  2003-09-23

7.  Micropatterning proteins and cells on polylactic acid and poly(lactide-co-glycolide).

Authors:  Chien-Chi Lin; Carlos C Co; Chia-Chi Ho
Journal:  Biomaterials       Date:  2005-06       Impact factor: 12.479

8.  Repair of segmental defects in rabbit humeri with titanium fiber mesh cylinders containing recombinant human bone morphogenetic protein-2 (rhBMP-2) and a synthetic polymer.

Authors:  Narumichi Murakami; Naoto Saito; Hiroshi Horiuchi; Takao Okada; Kazutoshi Nozaki; Kunio Takaoka
Journal:  J Biomed Mater Res       Date:  2002-11

9.  Bone formation on two-dimensional poly(DL-lactide-co-glycolide) (PLGA) films and three-dimensional PLGA tissue engineering scaffolds in vitro.

Authors:  Jeffrey M Karp; Molly S Shoichet; John E Davies
Journal:  J Biomed Mater Res A       Date:  2003-02-01       Impact factor: 4.396

Review 10.  Collagen sponges for bone regeneration with rhBMP-2.

Authors:  M Geiger; R H Li; W Friess
Journal:  Adv Drug Deliv Rev       Date:  2003-11-28       Impact factor: 15.470

View more
  3 in total

1.  Reply to Regarding the mechanism of action of a proposed peptide agonist of the bone morphogenetic protein receptor activin-like kinase 3.

Authors:  Hikaru Sugimoto; Valerie S LeBleu; Dattatreyamurty Bosukonda; Peter Keck; Gangadhar Taduri; Wibke Bechtel; Hirokazu Okada; William Carlson; Philippe Bey; Mary Rusckowski; Björn Tampe; Desiree Tampe; Keizo Kanasaki; Michael Zeisberg; Raghu Kalluri
Journal:  Nat Med       Date:  2013-07       Impact factor: 53.440

Review 2.  Novel approaches to bone grafting: porosity, bone morphogenetic proteins, stem cells, and the periosteum.

Authors:  Peter Petrochenko; Roger J Narayan
Journal:  J Long Term Eff Med Implants       Date:  2010

Review 3.  Drug delivery using composite scaffolds in the context of bone tissue engineering.

Authors:  Cecilia Romagnoli; Federica D'Asta; Maria Luisa Brandi
Journal:  Clin Cases Miner Bone Metab       Date:  2013-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.